Recent research highlighted the role of fungal strain-specific immune responses, such as candidalysin from C. albicans, in driving IL-1β-mediated inflammation, further suggesting fungi as pivotal contributors to IBD pathology (Li et al, 2022b). Here, IL1B is linked to inflammatory bowel disease.